Medication info
Lansira Capsule 15 mg (Lansoprazole Granules)

Lansira Capsule 15 mg (Lansoprazole Granules)

Prescription medicationHard capsuleOral
Ingredient · strength
Lansoprazole Granules›176.5mg / 1 capsule
Manufacturer / importer
Genupharm Co., Ltd.
Appearance
White to light brown granules in opaque white hard capsules.
Packaging
28 capsules/bottle, 100 capsules/bottle
Approval status
Active

MFDS item code 202002115 · Approved 2020.03.26 · Insurance code 698004230

Summary

Main use
Treatment, prevention, and eradication of gastric and duodenal ulcers; treatment of reflux disease; suppression of gastric acid hypersecretion
Who takes it
Adults · Children
Adult dose
This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice the amount of juice or more and drink immediately to ensure the entire dose is taken. Do not chew or crush the contents after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. If necessary, treatment may be given for up to 14 days. Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dosage of lansoprazole for pathological hypersecretory conditions varies for each patient. In adults, treatment is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be given in divided doses. Since clearance of this medicine is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer with caution, including consideration of dose adjustment.
Child dose
Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, over 30 kg: 30 mg once daily for 12 weeks

Ingredients

Manufacturer
Genupharm Co., Ltd.

Efficacy & effects

Treatment, prevention, and eradication of gastric and duodenal ulcers; treatment of reflux disease; suppression of gastric acid hypersecretion

  • Active duodenal ulcer
  • active benign gastric ulcer
  • duodenal ulcer
  • NSAIDs-induced gastric ulcer
  • symptoms related to gastroesophageal reflux disease
  • erosive gastroesophagitis
  • Zollinger-Ellison syndrome
  • pathological hypersecretion.
View approved original text

This medication is used for short-term treatment of active duodenal ulcers and gastric ulcers. It is also effective for eradication treatment to prevent recurrence of duodenal ulcers caused by Helicobacter pylori infection. It can be utilized as maintenance therapy after treatment of duodenal ulcers and helps in the treatment and risk reduction of gastric ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It applies to short-term treatment of gastroesophageal reflux disease and erosive gastroesophagitis and post-treatment maintenance. Finally, it is used to control pathological hypersecretion states such as Zollinger-Ellison syndrome. Overall, this medication improves recovery and prevention of recurrences of gastrointestinal diseases.

How to take

Adult dose

This medicine should be administered before meals. For patients who have difficulty swallowing the medicine, open the capsule, mix the contents with a small amount (60 mL) of orange juice or tomato juice, and administer immediately. Rinse the glass with twice the amount of juice or more and drink immediately to ensure the entire dose is taken. Do not chew or crush the contents after opening the capsule. Short-term treatment of active duodenal ulcers: Administer lansoprazole 15 mg orally once daily for 4 weeks. Short-term treatment of active benign gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. Eradication of Helicobacter pylori to prevent recurrence of duodenal ulcers Administer lansoprazole 30 mg with clarithromycin 250 ∼ 500 mg and amoxicillin 1,000 mg twice daily (every 12 hours) for 7 days. If necessary, treatment may be given for up to 14 days. Administer lansoprazole 30 mg in combination with amoxicillin 1,000 mg 3 times daily (every 8 hours) for 14 days. Maintenance therapy after treatment of duodenal ulcers: Administer lansoprazole 15 mg orally once daily. The comparative clinical trial period did not exceed 12 months. Treatment of NSAID-induced gastric ulcers: Administer lansoprazole 30 mg orally once daily for 8 weeks. The comparative clinical trial period did not exceed 8 weeks. Reduction of the risk of NSAID-induced gastric ulcers: Administer lansoprazole 15 mg orally once daily for 12 weeks. The comparative clinical trial period did not exceed 12 weeks. Short-term treatment of symptoms associated with gastroesophageal reflux disease Administer lansoprazole 15 mg orally once daily for 8 weeks. Short-term treatment of erosive reflux esophagitis: Administer lansoprazole 30 mg orally once daily for 8 weeks. Maintenance therapy after treatment of erosive reflux esophagitis: Administer lansoprazole 15 mg orally once daily. Pathological hypersecretory conditions, including Zollinger-Ellison syndrome The dosage of lansoprazole for pathological hypersecretory conditions varies for each patient. In adults, treatment is usually initiated at 60 mg once daily. The dose should be adjusted according to the patient's needs and may be continued for as long as it is clinically effective. Doses of 90 mg twice daily have been administered. If the daily dose exceeds 120 mg, it should be given in divided doses. Since clearance of this medicine is reduced in elderly patients, dose adjustment is necessary. Do not exceed a daily dose of 30 mg. Since metabolism and excretion of this medicine may be delayed in patients with hepatic impairment, administer with caution, including consideration of dose adjustment.

Child dose

Children and adolescents aged 12 ∼ 17 years, short-term treatment of symptoms associated with non-erosive gastroesophageal reflux disease: 15 mg once daily for 8 weeks Children and adolescents aged 12 ∼ 17 years, short-term treatment of erosive reflux esophagitis: 30 mg once daily for 8 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, 30 kg or less: 15 mg once daily for 12 weeks Children aged 1 ∼ 11 years, short-term treatment of symptoms associated with gastroesophageal reflux disease and erosive reflux esophagitis, over 30 kg: 30 mg once daily for 12 weeks

Precautions

This medication should not be used in patients with a known allergy to certain ingredients or benzimidazoles. It should also be avoided in patients with hypersensitivity to penicillin antibiotics or macrolide antibiotics. It is advisable not to use in pregnant or breastfeeding women as it is not considered safe. Caution should be taken when administering this medication to individuals with liver function issues, the elderly, children, or those with a history of drug allergies. During treatment with this medication, severe side effects such as allergic reactions, skin rashes, and breathing difficulties may occur, and careful observation is needed. Regular testing is required as liver or kidney dysfunction may occur, and immediate consultation with a specialist is necessary if abnormal symptoms appear. Long-term use may lead to vitamin B12 deficiency, and testing should be conducted if symptoms arise. This medication suppresses gastric acid secretion and may slightly increase the risk of gastrointestinal infections. Interactions with other medications may occur, so it is essential to inform about any other medications being taken, especially when used with antibiotics, antivirals, or anticoagulants. In cases of overdose, appropriate medical treatment should be sought immediately, as it cannot be removed by blood dialysis. Store out of reach of children, and it is safer not to transfer to another container. If long-term use occurs or abnormal symptoms arise during use, consult a physician or pharmacist.

Side effects

Anaphylactic reaction, generalized rash, facial edema, dyspnea, shock, pancytopenia, agranulocytosis, hemolytic anemia, neutropenia, thrombocytopenia, anemia, jaundice, elevated AST, elevated ALT, toxic liver dysfunction, toxic epidermal necrolysis, Stevens-Johnson syndrome, DRESS syndrome, interstitial pneumonia, fever, cough, abnormal lung sounds, interstitial nephritis, acute renal failure, membrane colitis, hematochezia, abdominal pain, diarrhea, headache, abdominal enlargement, allergic reaction, back pain, weakness, candidiasis, neoplasm, chills, chest pain, edema, fever, flu-like symptoms, halitosis, infection, fatigue, neck stiffness, pelvic pain, angina pectoris, arrhythmia, bradycardia, tachycardia, cerebrovascular accident, cerebral infarction, hypertension, hypotension, migraine, myocardial infarction, palpitations, vasodilation, syncope, asthma, bronchitis, increased cough, epistaxis, hemoptysis, hiccups, pneumonia, upper respiratory infection, laryngeal tumor, pulmonary fibrosis, pharyngitis, pleural disorder, respiratory disorder, rhinitis, sinusitis, wheezing, abnormal stool, enteritis, gastritis, gastric abnormality, gastrointestinal disease, gastrointestinal bleeding, loss of appetite, gastric calculus, pyloric spasm, cholelithiasis, constipation, dry mouth, thirst, dyspepsia, dysphagia, belching, esophageal stricture, esophagitis, esophageal ulcer, stool discoloration, abdominal distension, gastric nodule, gastric gland polyp, gastritis, gastric and duodenal bleeding, hematemesis, increased appetite, increased saliva, anal bleeding, stomatitis, tongue disease, glossitis, gingival bleeding, postprandial discomfort, colitis, vomiting, nausea, diarrhea, gastrointestinal candidiasis, rectal disease, rectal bleeding, diabetes mellitus, goiter, hypothyroidism, anemia, bleeding, lymphadenopathy, vitamin deficiency, gout, hyperglycemia, hypoglycemia, dehydration, weight gain, weight loss, peripheral edema, bone disease, joint disease, leg cramps, arthritis, arthralgia, musculoskeletal pain, myalgia, myasthenia gravis, ptosis, synovitis, anxiety, memory loss, anxiety, apathy, confusion, depression, dizziness, syncope, hallucinations, unilateral paralysis, worsening hostility, decreased libido, increased libido, neurosis, sensory disturbance, abnormal thinking, convulsions, dementia, depersonalization, double vision, hyperkinesis, hypertonia, decreased sensation, insomnia, sleep disturbances, drowsiness, tremors, acne, hair loss, pruritus, rash, urticaria, contact dermatitis, dry skin, nail disease, skin cancer, skin disease, sweating, abnormal vision, amblyopia, blepharitis, cataract, conjunctivitis, dry eyes, ear disease, eye disease, glaucoma, abnormal olfaction, photophobia, retinal degeneration, loss of taste, blurred vision, deafness, ocular pain, otitis media, altered taste, tinnitus, visual field narrowing, urinary dysfunction, renal pain, penile disease, testicular disease, urethral pain, polyuria, frequent urination, urine retention, menstrual irregularities, chest tenderness, chest expansion, gynecomastia, diabetes, hematuria, erectile dysfunction, nephrolithiasis, abdominal pain, altered taste, stool changes, abdominal bloating, nausea, vomiting, stomatitis, glossitis, heartburn, gastroesophageal reflux, loss of appetite, increased AST, increased ALT, increased ALP, increased LDH, increased γ-GTP, elevated bilirubin, neutropenia, eosinophilia, leukocytosis, thrombocytopenia, rash, itching, headache, drowsiness, dizziness, insomnia, paralysis, depressive state, increased triglycerides, elevated uric acid, increased total cholesterol, decreased total cholesterol, positive urine protein, positive urine glucose, fatigue, hepatotoxicity, pancreatitis, taste disorder, agranulocytosis, aplastic anemia, thrombotic thrombocytopenic purpura, eosinophilia, hypomagnesemia, Clostridium difficile associated diarrhea, fracture, myositis, erythema multiforme, speech disorder, urinary retention, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated γ-GTP, fatigue, hyponatremia, elevated total cholesterol, elevated uric acid, gynecomastia, tongue paralysis, lip paralysis, limb paralysis

Not everyone experiences these, and they can vary from person to person.

Storage

Keep this medication in a tightly closed container to prevent air or moisture from entering, and store at room temperature between 1 to 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White to light brown granules in opaque white hard capsules.

Package unit

28 capsules/bottle, 100 capsules/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.